Why the study?
Tachycardia or bradycardia in atrial fibrillation often reflects an ongoing pathological process, and early recognition of potential life-threatening arrhythmia in the outpatient setting leads to appropriate clinical management.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Early recognition of digoxin toxicity and prompt administration of digoxin-specific antibody fragments is crucial for reversing life-threatening bradycardia.
General practitioners regularly encounter atrial fibrillation in their daily practice. A crucial cornerstone of its management includes prescribing anticoagulants and controlling the heart rate. Tachycardia or bradycardia often reflects an ongoing pathological process that should be addressed. Clues are frequently revealed through comprehensive history-taking, complete physical assessment and 12-lead electrocardiogram (ECG) interpretation at the bedside. Thus, early recognition of potential life-threatening arrhythmia in the outpatient setting will lead to appropriate clinical management. In this paper, we illustrate a sudden decrease in the heart rate of a patient with atrial fibrillation. We discuss the ECG interpretation, potential differential diagnoses and approach to clinical management.
No takes yet. Share an insight, caveat, or question.
Goh et al. (2023) conducted a case report in Digoxin toxicity with bradycardia in atrial fibrillation (n=1). Digoxin-specific antibody fragments (Digibind) was evaluated on Normalization of heart rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: